Bristol OTC Stock Probability of Future OTC Stock Price Finishing Under 990.03

BMYMP
 Stock
  

USD 1,200  10.00  0.84%   

Bristol Myer's future price is the expected price of Bristol Myer instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Bristol Myer Squi performance during a given time horizon utilizing its historical volatility.
  
Continue to Bristol Myer Backtesting, Bristol Myer Valuation, Bristol Myer Correlation, Bristol Myer Hype Analysis, Bristol Myer Volatility, Bristol Myer History as well as Bristol Myer Performance. Please specify Bristol Myer time horizon, a valid symbol (red box) and a target price (blue box) you would like Bristol Myer odds to be computed.

Bristol Myer Target Price Odds to finish below 990.03

The tendency of Bristol OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 990.03  or more in 90 days
 1,200 90 days 990.03 
near 1
Based on a normal probability distribution, the odds of Bristol Myer to drop to $ 990.03  or more in 90 days from now is near 1 (This Bristol Myer Squi probability density function shows the probability of Bristol OTC Stock to fall within a particular range of prices over 90 days) . Probability of Bristol Myer Squi price to stay between $ 990.03  and its current price of $1200.0 at the end of the 90-day period is about 53.93 .
Assuming the 90 days horizon Bristol Myer Squi has a beta of -0.22 suggesting as returns on benchmark increase, returns on holding Bristol Myer are expected to decrease at a much lower rate. During the bear market, however, Bristol Myer Squi is likely to outperform the market. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Bristol Myer Squi is significantly underperforming DOW.
   Bristol Myer Price Density   
       Price  

Predictive Modules for Bristol Myer

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bristol Myer Squi. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Bristol Myer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Bristol Myer in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
1,1981,2001,202
Details
Intrinsic
Valuation
LowReal ValueHigh
1,0061,0081,320
Details
Naive
Forecast
LowNext ValueHigh
1,2371,2391,241
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1,1301,1911,252
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bristol Myer. Your research has to be compared to or analyzed against Bristol Myer's peers to derive any actionable benefits. When done correctly, Bristol Myer's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Bristol Myer Squi.

Bristol Myer Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bristol Myer is not an exception. The market had few large corrections towards the Bristol Myer's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bristol Myer Squi, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bristol Myer within the framework of very fundamental risk indicators.
α
Alpha over DOW
-0.16
β
Beta against DOW-0.22
σ
Overall volatility
73.03
Ir
Information ratio -0.0078

Bristol Myer Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bristol Myer for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bristol Myer Squi can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Bristol Myer Squi generated a negative expected return over the last 90 days
On 1st of September 2022 Bristol Myer paid $ 0.5 per share dividend to its current shareholders
Latest headline from www.nytimes.com: Weather Updates Wildfires Scorch the West After Record Heat - The New York Times

Bristol Myer Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bristol OTC Stock often depends not only on the future outlook of the current and potential Bristol Myer's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bristol Myer's indicators that are reflective of the short sentiment are summarized in the table below.
Trailing Annual Dividend Rate1.59
Average Daily Volume Last 10 Day1
Trailing Annual Dividend Yield0.13%

Bristol Myer Technical Analysis

Bristol Myer's future price can be derived by breaking down and analyzing its technical indicators over time. Bristol OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bristol Myer Squi. In general, you should focus on analyzing Bristol OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Bristol Myer Predictive Forecast Models

Bristol Myer time-series forecasting models is one of many Bristol Myer's otc stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bristol Myer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Bristol Myer Squi

Checking the ongoing alerts about Bristol Myer for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bristol Myer Squi help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bristol Myer Squi generated a negative expected return over the last 90 days
On 1st of September 2022 Bristol Myer paid $ 0.5 per share dividend to its current shareholders
Latest headline from www.nytimes.com: Weather Updates Wildfires Scorch the West After Record Heat - The New York Times
Continue to Bristol Myer Backtesting, Bristol Myer Valuation, Bristol Myer Correlation, Bristol Myer Hype Analysis, Bristol Myer Volatility, Bristol Myer History as well as Bristol Myer Performance. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for analysis

When running Bristol Myer Squi price analysis, check to measure Bristol Myer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myer is operating at the current time. Most of Bristol Myer's value examination focuses on studying past and present price action to predict the probability of Bristol Myer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol Myer's price. Additionally, you may evaluate how the addition of Bristol Myer to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Bristol Myer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myer. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bristol Myer Squi is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myer's value that differs from its market value or its book value, called intrinsic value, which is Bristol Myer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myer's market value can be influenced by many factors that don't directly affect Bristol Myer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myer's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol Myer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.